Bone-specific alkaline phosphatase as a marker of bone formation: Clinical and imaging correlates
Abstract
Bone-specific alkaline phosphatase (BSAP) is a biochemical marker of bone formation, reflecting osteoblast function and bone turnover. Unlike bone mass and structure measurements using dual-energy X-ray absorptiometry or high-resolution peripheral quantitative computed tomography, BSAP does not directly measure bone mass or microarchitecture but provides dynamic information on bone metabolism. BSAP has high specificity for bone formation with low biological variability and consistent levels across many clinical conditions, making it a reliable biochemical indicator of bone turnover, especially early response to anabolic treatment and in high-turnover bone conditions. Biologically, BSAP is synthesized by osteoblasts and is important in matrix maturation and mineralisation. In clinical practice, BSAP increases with anabolic treatment, often before changes in bone density, and is thus a predictor of early treatment response. Low levels of BSAP are found in conditions with delayed fracture healing, such as hypophosphatasia, and high levels are found in high-turnover conditions such as Paget's disease. BSAP also has a role in conditions such as chronic kidney disease, where it can discriminate between states of bone turnover. However, its use is hampered by variability between laboratories, the absence of reference ranges, and the lack of normative data in different populations. Novel methods combining BSAP with innovative imaging techniques have the potential to improve…
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.